Tag: Atrial Fibrillation
Ablation Better Than Medical Tx for A-Fib With Heart Failure
Catheter ablation significantly lowers death rate from any cause, hospitalization for worsening CHF
Characteristics of Asymptomatic Paroxysmal A-Fib Identified
All-cause mortality significantly higher in asymptomatic versus symptomatic patients with PAF
Closure of Patent Foramen Ovale Cuts Recurrent Stroke/TIA Risk
Reviews demonstrate reduction in recurrent stroke risk after percutaneous transcatheter PFO closure
Follow-Up Delta CHA2DS2-VASc Score Better Predicts CVA in A-Fib
CHA2DS2-VASc score not static; most a-fib patients develop new risk factor before ischemic stroke
Interruption of Apixaban Doesn’t Impact Bleeding in A-Fib
Similarly low rate of thromboembolic events with uninterrupted, minimally interrupted apixaban
USPSTF Reviews Use of ECG for Preventing A-Fib, CVD Events
I statement for use of ECG in A-fib in seniors; D recommendation against ECG for reducing CVD risk
In-Hospital Deaths in A-Fib Patients Higher in Rural Areas
Risk of death is 17 percent higher in rural versus urban hospitals
Specialty Care Tied to Reduced Mortality in New-Onset A-Fib
Finding despite increased rates of hospitalizations and other cardiovascular outcomes
Ablation Cuts Risk of Recurrent Stroke in Patients With A-Fib
Patients with AF with no ablation have increased five-year risk of CVA, death versus ablated patients
NOACs Show Lower Risk of Adverse Renal Outcomes in A-Fib
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
